DYRK1B and ovarian cancer: As listed in Table I, in this study we not only examined Mirk expression in ovarian cancer specimens included 38 serous and 13 mucinous but also 16 benign cystadenomas and 9 non-neoplastic ovarian cysts by immunohistochemisty.